Insulin Market in China 2014-2018
|出版商||TechNavio (Infiniti Research Ltd.)||商品編碼||317341|
|出版日期||內容資訊||英文 78 Pages
Insulin is a hormone produced in the pancreas. It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the food for energy or to store glucose for future use. Various types of insulin exist depending on how quickly they work, when they peak, and how long they last. In diabetic condition, the pancreas no longer produces adequate insulin or the cells stop responding to the insulin that is produced, leading to rise in blood glucose level.
TechNavio's analysts forecast the Insulin market in China to grow at a CAGR of 15.57 percent over the period 2013-2018.
The Insulin market in China can be divided into two segments: Recombinant Insulin and Modern Insulin. This report covers the present scenario and the growth prospects of the Insulin market in China for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various second and third generation insulin products.
TechNavio's report, Insulin Market in China 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Insulin market landscape in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.